Leaderboards/Kawasaki Disease and Coronary Complications

Kawasaki Disease and Coronary Complications

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Rebecca A. Porritt
Sanford Burnham Prebys Medical Discovery Institute
2
Jennifer Loske
Humboldt-Universität zu Berlin
3
Miranda J. Delahoy
Centers for Disease Control and Prevention
4
Xuyan Shi
National Institute of Biological Sciences, Beijing
5
Taisho Yamada
Kyushu University
6
Zahra Belhadjer
Hôpital Necker-Enfants Malades
7
Huanzhou Xu
Wuhan Institute of Virology
8
Danyel Lee
Inserm
9
Yifan Que
Chinese PLA General Hospital
10
Carl Christoph Goetzke
German Rheumatism Research Centre

Papers

1
Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine|2024
48 cit.
2
Leveraging the interconnected unfolded protein response and NLRP3 inflammasome pathways to reactivate Epstein–Barr virus in diffuse large B-cell lymphomas
NAR Cancer|2025
5 cit.
3
Publication in Science Immunology (2026) [4 citations, W7120101806]
Science Immunology|2026
4 cit.
4
Increased aortic pressures and pulsatile afterload components promote concentric left ventricular remodeling in adults with transposition of the great arteries and arterial switch operation
International Journal of Cardiology|2024
3 cit.
5
STAT3, MYC, and EBNA1 cooperate through a ZC3H18 transcriptional network to regulate survival and proliferation of EBV-positive lymphomas
PLoS Pathogens|2025
2 cit.
6
The particular anatomy of atrioventricular septal defect with a common valvar orifice in patients with Down syndrome: an echocardiographic study
International Journal of Cardiology|2025
1 cit.
7
Pharmakologische Aktivierung der CFTR-Funktion verbessert die Homöostase des Atemwegsepithels und die Immunabwehr bei Kindern mit Mukoviszidose
Klinische Pädiatrie|2024
0 cit.
8
WS05.03 Pharmacological improvement of CFTR function rescues airway epithelial homeostasis and host defense in children with cystic fibrosis
Journal of Cystic Fibrosis|2024
0 cit.
9
P-2354. Neonatal Enterovirus and Parechovirus Infections—National Enterovirus Surveillance System, United States, 2004–2022
Open Forum Infectious Diseases|2025
0 cit.
10
Neonatal Enterovirus and Parechovirus Infections: National Enterovirus Surveillance System, United States, 2004–2023
The Pediatric Infectious Disease Journal|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Slimane Allali
Inserm
2
Nils Landegren
Science for Life Laboratory
3
Shana Godfred‐Cato
University of Utah
4
Roshni Mathew
Stanford Medicine
5
Travis Eastin
University of Arkansas for Medical Sciences
6
Jonathan M. Wortham
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention
7
Erin E. West
National Heart Lung and Blood Institute
8
Bérengère Dalichoux
Nomura Holdings (Japan)
9
Andrea George
Dermatology Specialists
10
Julie Williams
University Of Bristol Dental Hospital

Papers

1
HbS promotes TLR4-mediated monocyte activation and proinflammatory cytokine production in sickle cell disease
Blood|2022
55 cit.
2
Loss of CD4+ T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection
Immunity|2023
49 cit.
3
Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023
MMWR Morbidity and Mortality Weekly Report|2024
21 cit.
4
Tuberculosis Outbreaks in State Prisons, United States, 2011–2019
American Journal of Public Health|2022
11 cit.
5
Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea (<scp>ESCORT‐HU</scp>) study
American Journal of Hematology|2024
11 cit.
6
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
npj Vaccines|2024
7 cit.
7
Vaccine Acceptance During a Novel Student-led Emergency Department COVID-19 Vaccination Program
Western Journal of Emergency Medicine|2023
6 cit.
8
Long-term Health Outcomes After Hospital Discharge Among Children Hospitalized for MIS-C or COVID-19, September 29, 2021, to June 21, 2022
The Pediatric Infectious Disease Journal|2024
6 cit.
9
Oral famotidine reduces the plasma level of soluble P‐selectin in children with sickle cell disease
British Journal of Haematology|2023
4 cit.
10
Sputum interleukin‐6 level as a marker of severity during acute chest syndrome in children with sickle cell disease
British Journal of Haematology|2024
4 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jessica Manson
University College London Hospitals NHS Foundation Trust
2
Jane C. Burns
Rady Children's Hospital-San Diego
3
Adrienne G. Randolph
The Centers
4
Jane W. Newburger
Oregon Health & Science University
5
Hiroshi Yanagawa
Keio University
6
Kathryn A. Taubert
Southwestern Medical Center
7
Michael Levin
University of Chicago
8
Lorenzo D’Antiga
Ospedale Papa Giovanni XXIII
9
Marco Metra
Vita-Salute San Raffaele University
10
Marian E. Melish
Kapiolani Medical Center for Women and Children

Papers

1
COVID-19: consider cytokine storm syndromes and immunosuppression
The Lancet|2020
10.2k cit.
2
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
New England Journal of Medicine|2020
2.7k cit.
3
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
The Lancet|2020
2.5k cit.
4
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
Circulation|2006
2.1k cit.
5
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Circulation|2004
1.9k cit.
6
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
JAMA Cardiology|2020
1.9k cit.
7
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Circulation|2011
1.8k cit.
8
Infective Endocarditis
Circulation|2005
1.7k cit.
9
A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan
PEDIATRICS|1974
1.5k cit.
10
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
PEDIATRICS|2004
1.4k cit.

Reagents for Kawasaki Disease and Coronary Complications

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

R&D SystemsEvidence 64

Mouse IL-1 beta/IL-1F2 Antibody

#AF-401-NA (also AF-401-SP)
View Evidence →
Cell Signaling TechnologyEvidence 70

STING (D1V5L) Rabbit Monoclonal Antibody

#50494$175,351
View Evidence →
Cell Signaling Technology

CUL1 Antibody

#4995$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

BCA Protein Assay Kit

Cited in 6 papers
#7780$410
View Evidence →
Cell Signaling TechnologyEvidence 68

ASC/TMS1 (D2W8U) Rabbit Monoclonal Antibody

#67824$151,351
View Evidence →
Cell Signaling TechnologyEvidence 66

Caspase-1 Antibody

#2225$137,317
View Evidence →